Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.

Opinion | Preserve the National Institute of Nursing Research’s Independence

Darcy-Mahoney is a professor, neonatal nurse practitioner, researcher, and educator. Menon is the dean of a college of nursing. Murray is dean emerita, professor, and

November 23, 2024

First U.S. trial uses non-viral CRISPR to correct sickle cell mutation

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease.

November 26, 2024

CinRx touts positive early-stage data from two obesity candidates

CinFina Pharma, a subsidiary of the hub-and-spoke biotech CinRx, shared early-stage data for two of its Janssen-licensed obesity candidates at this year’s ObesityWeek. CIN-110, a

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.